Cellectis Ownership | Who Owns Cellectis?
Cellectis Ownership Summary
Cellectis is owned by 0.13% institutional investors, and 99.87% retail investors. B group is the largest institutional shareholder, holding 3.27% of CLLS shares. American Funds SMALLCAP World A is the top mutual fund, with 1.85% of its assets in Cellectis shares.
CLLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cellectis | 0.13% | - | 99.87% |
| Sector | Healthcare Stocks | 50.44% | 12.38% | 37.18% |
| Industry | Biotech Stocks | 48.97% | 12.07% | 38.96% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| B group | 3.28M | 3.27% | $10.40M |
| Ubs asset management americas | 3.18M | 3.17% | $10.08M |
| Long focus capital management | 2.74M | 2.74% | $8.70M |
| Millennium management | 534.55K | 0.53% | $962.19K |
| Blackrock funding, inc. /de | 341.52K | 0.34% | $1.08M |
| Macquarie management | 226.88K | 0.23% | $719.00K |
| Morgan stanley | 86.78K | 0.09% | $275.08K |
| Lpl financial | 84.34K | 0.08% | $267.37K |
| Susquehanna group, llp | 65.94K | 0.07% | $209.04K |
| Bnp paribas arbitrage, snc | 41.00K | 0.04% | $129.97K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| B group | 3.28M | 7.71% | $10.40M |
| Long focus capital management | 2.74M | 0.23% | $8.70M |
| Delaney dennis r | 24.00K | 0.03% | $76.08K |
| Eversource wealth advisors | 5.08K | 0.02% | $524.86K |
| First affirmative financial network | 10.15K | 0.01% | $28.93K |
| Virtu financial | 25.21K | 0.00% | $72.00K |
| Ubs asset management americas | 3.18M | 0.00% | $10.08M |
| Pom investment strategies | 495.00 | 0.00% | $1.57K |
| Macquarie management | 226.88K | 0.00% | $719.00K |
| Xtx topco | 16.27K | 0.00% | $51.57K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 534.55K | 0.00% | 534.55K |
| Virtu financial | 25.21K | 0.00% | 25.21K |
| Xtx topco | 16.27K | 0.00% | 16.27K |
| Susquehanna group, llp | 65.94K | - | 13.52K |
| First affirmative financial network | 10.15K | 0.01% | 10.15K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -1.85M |
| Principal financial group | - | - | -411.80K |
| Macquarie group | - | - | -226.88K |
| Kbc group nv | - | - | -163.45K |
| Baillie gifford | - | - | -139.05K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Millennium management | 534.55K | 0.00% | 534.55K | $962.19K |
| Virtu financial | 25.21K | 0.00% | 25.21K | $72.00K |
| Xtx topco | 16.27K | 0.00% | 16.27K | $51.57K |
| First affirmative financial network | 10.15K | 0.01% | 10.15K | $28.93K |
| Global retirement partners | 7.04K | 0.00% | 7.04K | $34.06K |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Citigroup | -1.00 |
| Toronto dominion bank | -31.00 |
| Frg family wealth advisors | -80.00 |
| Group one trading | -97.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 9 | -73.53% | 129,598 | -98.77% | - | 0.12% | 1 | -94.74% | 6 | 20.00% |
| Dec 31, 2025 | 20 | -31.03% | 4,043,805 | -51.35% | 4 | 5.87% | 13 | - | 2 | -66.67% |
| Sep 30, 2025 | 27 | 17.39% | 8,300,546 | -29.28% | 8 | 6.04% | 13 | 62.50% | 5 | -28.57% |
| Jun 30, 2025 | 22 | -18.52% | 11,737,843 | -13.71% | 11 | 6.33% | 7 | -22.22% | 7 | -12.50% |
| Mar 31, 2025 | 27 | -12.90% | 13,602,212 | 6.61% | 13 | 8.36% | 9 | -25.00% | 8 | 33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 1.85M | 1.85% | - |
| UBS (Lux) Digital Health Equity SB USD | 1.44M | 1.44% | - |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 1.30M | 1.30% | - |
| Principal U.S. Small Cap Equity | 289.60K | 0.29% | -4.40K |
| iShares Biotechnology ETF | 229.87K | 0.23% | -699.00 |
| Delaware Healthcare I | 226.88K | 0.23% | - |
| Macquarie Healthcare I | 226.88K | 0.23% | - |
| Nomura Healthcare Fund Class I | 226.88K | 0.23% | - |
| Galileo - Biotech Innovation Fund S USD | 226.07K | 0.22% | - |
| Principal SmallCap R5 | 199.15K | 0.20% | -90.45K |
CLLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools